APA (7th ed.) Citation

MN, H., FR, C., KMK, I., CA, S., & MT, I. (2026). Antiphospholipid Antibodies in Severe COVID-19: Frequency, Clinical Features, and 12-Week Follow-Up. Cureus, 18(1), e100657. https://doi.org/10.7759/cureus.100657

Chicago Style (17th ed.) Citation

MN, Hasan, Chowdhury FR, Islam KMK, Sami CA, and Islam MT. "Antiphospholipid Antibodies in Severe COVID-19: Frequency, Clinical Features, and 12-Week Follow-Up." Cureus 18, no. 1 (2026): e100657. https://doi.org/10.7759/cureus.100657.

MLA (9th ed.) Citation

MN, Hasan, et al. "Antiphospholipid Antibodies in Severe COVID-19: Frequency, Clinical Features, and 12-Week Follow-Up." Cureus, vol. 18, no. 1, 2026, p. e100657, https://doi.org/10.7759/cureus.100657.